Gil Leibowitz
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
European Foundation for the Study of Diabetes
EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe, Fructose is central in diabetic kidney disease and mediates the protective effects of SGLT2 inhibitors, EFSD-nn-as-diab-research-europe-2022-gil-leibowitz, 2022, 1 Jan 2022
Sources: openalex.org